<DOC>
	<DOCNO>NCT00632840</DOCNO>
	<brief_summary>The purpose study determine whether atorvastatin fenofibrate effective treatment lipid disorder obese , insulin resistant subject .</brief_summary>
	<brief_title>Pharmacological Regulation Fat Transport Metabolic Syndrome</brief_title>
	<detailed_description>Insulin resistance heterogeneous metabolic disorder complex etiology . It underpin dyslipoproteinemia , key feature metabolic syndrome ( MetS ) independently predict cardiovascular disease ( CVD ) . Hypertriglyceridemia , consistent lipid disorder subject obesity type 2 diabetes mellitus , chiefly consequence overproduction delay clearance triglyceride-rich lipoprotein ( TRLs ) . Although precise mechanism involve incompletely understood , experimental clinical evidence suggest elevate apolipoprotein ( apo ) C-III may play crucial role dysregulation TRL metabolism . investigate effect agent VLDL-apoC-III kinetics . In study , aim examine effect two lipid-regulating agent , atorvastatin fenofibrate VLDL-apoC-III transport . We hypothesize atorvastatin fenofibrate would similar effect apoC-III transport decrease production increase catabolism VLDL-apoC-III .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<criteria>three following waist circumference &gt; 102cm triglyceride &gt; 1.7 mmol/L HDLcholesterol &lt; 1.05 mmol/L blood glucose &gt; 6.1 mmol/L blood pressure &gt; 130/85mmHg plasma cholesterol &gt; 7mmo/L triglyceride &gt; 4.5mmo/L diabetes mellitus ( define oral glucose tolerance test ) CVD consumption &gt; 30g alcohol/day use agent affect lipid metabolism APOE2/E2 genotype , macroproteinuria creatinaemia ( &gt; 120umol/L ) hypothyroidism abnormal liver muscle enzyme .</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>